Syringe Overwrap (Ephedrine Sulfate Injection 1)
Ephedrine Sulfate Injection
Product Images NDC 0641-6236
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ephedrine Sulfate (NDC 0641-6236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Ephedrine Sulfate Injection 2)
Ephedrine Sulfate Injection Structural Formula (Ephedrine Sulfate Injection 3)
Unit Label (Ephedrine Sulfate Injection 4)
Ephedrine Pfs Carton (Ephedrine Sulfate Injection 5)
Each mL of this ephedrine sulfate injection contains 5 mg of ephedrine sulfate, USP, equivalent to 3.8 g of ephedrine base, and 8.6 mg of sodium chloride, USP in Water for Injection, USP. The pH is adjusted with Sodium Hydroxide NF to 4.5-6.5. This medication is intended for intravenous use, typically administered in surgical procedures. The prefillc syringe is for single-patient use. It should be stored between 20°C to 25°C (68°F to 77°F) with excursions allowed to 15°C to 30°C (59°F to 86°F). This product is manufactured by Hikma in Berkeloy Heights, NJ, USA. The dosage information can be found in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
